Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0002050492-25-000003·Actyus Private Equity SGIIC, S.A.
Schedule 13G ownership disclosure
Elicio Therapeutics, Inc.
Common Stock, par value $0.01 per share · CUSIP: 28657F103
Event date: 2025-09-30
- Filing-level shares
- 268,564.00
- Percent of class
- 1.6%
- Actyus Private Equity SGIIC, S.A.
Shares: 268,564.00 · Class: 1.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002050492-25-000003
- Form type
- SCHEDULE 13G/A
- Filer
- Actyus Private Equity SGIIC, S.A.
- CIK
- CIK 2050492
- Filed
- Oct 07, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership